The Patent Finder

Terms ending in 2032

Translate Bio, Inc.

Every in-force patent on Translate Bio, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,143,758Liver Specific Delivery of Messenger RNA
In force
 · Medium confidence
Translate Bio, Inc.In forceMedium confidence
US 11,224,642Mrna Therapy for Argininosuccinate Synthetase Deficiency
In force
 · High confidence
Translate Bio, Inc.In forceHigh confidence
US 9,308,281Mrna Therapy for Fabry Disease
In force
 · Low confidence
Translate Bio, Inc.In forceLow confidence
US 9,597,413Pulmonary Delivery of Mrna
In force
 · Low confidence
Translate Bio, Inc.In forceLow confidence
US 10,238,754Lipid Nanoparticle Compositions and Methods for Mrna Delivery
In force
 · Low confidence
Translate Bio, Inc.In forceLow confidence
US 10,350,303Lipid Nanoparticle Compositions and Methods for Mrna Delivery
In force
 · Low confidence
Translate Bio, Inc.In forceLow confidence
US 10,413,618Lipid Nanoparticle Compositions and Methods for mRNA Delivery
In force
 · Low confidence
Translate Bio, Inc.In forceLow confidence
US 10,507,183Cleavable Lipids
In force
 · High confidence
Translate Bio, Inc.In forceHigh confidence
US 10,507,249Lipid Nanoparticle Compositions and Methods for Mrna Delivery
In force
 · Low confidence
Translate Bio, Inc.In forceLow confidence
US 10,888,626Lipid Nanoparticle Compositions and Methods for Mrna Delivery
In force
 · Low confidence
Translate Bio, Inc.In forceLow confidence
20 more term ends in 2032 · Pro
10 of 30 patents shown. Soonest term end first, then patent number.
Pro members see all 30.
Upgrade to Pro
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited